rs1060501784

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_005591.4(MRE11):​c.16G>T​(p.Ala6Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A6T) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 1 hom. )
Failed GnomAD Quality Control

Consequence

MRE11
NM_005591.4 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.510

Publications

0 publications found
Variant links:
Genes affected
MRE11 (HGNC:7230): (MRE11 homolog, double strand break repair nuclease) This gene encodes a nuclear protein involved in homologous recombination, telomere length maintenance, and DNA double-strand break repair. By itself, the protein has 3' to 5' exonuclease activity and endonuclease activity. The protein forms a complex with the RAD50 homolog; this complex is required for nonhomologous joining of DNA ends and possesses increased single-stranded DNA endonuclease and 3' to 5' exonuclease activities. In conjunction with a DNA ligase, this protein promotes the joining of noncomplementary ends in vitro using short homologies near the ends of the DNA fragments. This gene has a pseudogene on chromosome 3. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
MRE11 Gene-Disease associations (from GenCC):
  • ataxia-telangiectasia-like disorder 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • prostate cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.060568124).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005591.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MRE11
NM_005591.4
MANE Select
c.16G>Tp.Ala6Ser
missense
Exon 2 of 20NP_005582.1
MRE11
NM_001440460.1
c.16G>Tp.Ala6Ser
missense
Exon 2 of 21NP_001427389.1
MRE11
NM_001440461.1
c.16G>Tp.Ala6Ser
missense
Exon 2 of 21NP_001427390.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MRE11
ENST00000323929.8
TSL:1 MANE Select
c.16G>Tp.Ala6Ser
missense
Exon 2 of 20ENSP00000325863.4
MRE11
ENST00000323977.7
TSL:1
c.16G>Tp.Ala6Ser
missense
Exon 2 of 19ENSP00000326094.3
MRE11
ENST00000540013.5
TSL:1
c.16G>Tp.Ala6Ser
missense
Exon 2 of 8ENSP00000440986.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000137
AC:
2
AN:
1461650
Hom.:
1
Cov.:
32
AF XY:
0.00000275
AC XY:
2
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5672
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111918
Other (OTH)
AF:
0.00
AC:
0
AN:
60382
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Feb 28, 2020
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.A6S variant (also known as c.16G>T), located in coding exon 1 of the MRE11A gene, results from a G to T substitution at nucleotide position 16. The alanine at codon 6 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
8.3
DANN
Benign
0.63
DEOGEN2
Benign
0.057
T
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.75
T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.061
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.41
N
PhyloP100
-0.51
PrimateAI
Benign
0.38
T
PROVEAN
Benign
0.60
N
REVEL
Benign
0.15
Sift
Benign
0.57
T
Sift4G
Benign
0.81
T
Polyphen
0.0
B
Vest4
0.074
MutPred
0.14
Gain of disorder (P = 0.053)
MVP
0.55
MPC
0.077
ClinPred
0.029
T
GERP RS
-0.17
Varity_R
0.032
gMVP
0.41
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060501784; hg19: chr11-94225952; API